Rusi Pharma Pvt Ltd, a active private limited company, was established on 16 October 1992 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230MH1992PTC069066. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹5.00 M.
It upholds a compliant status. Its leadership includes Monika (Additional Director), Sudhir Kumar (Additional Director). Past directors included Monika, Amit Sharma, Saksham Gilhotra. It holds no open charges and ₹6.01 Cr settled loans. Its latest AGM occurred on 03 October 2020, with the balance sheet filed on 31 March 2020. It is based at Anchor Building A,Flat No.4D/104, New Mhada Complex Bhoomi Construction, Malwani Mal, Ad West, Mumbai, Maharashtra, 400096.
U24230MH1992PTC069066
069066
16 October 1992
₹5.00 M
₹5.00 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Rusi Pharma Pvt Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Monika | Additional Director | 28 Jun 2021 | Current |
| Sudhir Kumar | Additional Director | 25 Jan 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 23 Mar 2021 | Past |
| Pramod Abcsdd | Additional Director | 03 Jul 2017 | Past |
| Pramod Abcsdd | Additional Director | 09 May 2018 | Past |
| Pramod Abcsdd | Additional Director | 19 Dec 2023 | Past |
| Pramod Abcsdd | Director | 01 Mar 2017 | Past |
| Pramod Abcsdd | Director | 22 Jan 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Rusi Pharma Pvt Ltd, for the financial year ended 2016, experienced significant growth in revenue, with a 130.93% increase. The company also saw a slight improvement in profitability, with a 1.24% increase in profit. The company's net worth observed a substantial decline by a decrease of 28.92%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Rusi Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹60,100,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jul 2004 | Bank Of Baroda | ₹5.70 Cr | Satisfied |
| 05 Feb 2000 | Central Bank Of India | ₹2.00 M | Satisfied |
| 27 May 1997 | The Saraswat Co-Op Bank Ltd | ₹0.30 M | Satisfied |
| 19 Jun 1996 | The Saraswat Co-Op Bank Ltd | ₹0.40 M | Satisfied |
| 18 Jun 1993 | The Saraswat Co-Op Bank Ltd | ₹0.40 M | Satisfied |
Explore comprehensive loan charge details -
Rusi Pharma has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Rusi Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rusi Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Monika was appointed as a Additional Director was appointed as a Additional Director on 28 Jun 2021 & has been associated with this company since 4 years 5 months . was recorded as a recent event.
Progress on Rusi Pharma Pvt Ltd last Annual general meeting of members was held on 03 Oct 2020 as per latest MCA records. was documented.
The activity Rusi Pharma Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Mumbai. was completed.
The activity Sudhir Kumar was appointed as a Additional Director was appointed as a Additional Director on 25 Jan 2019 & has been associated with this company since 6 years 10 months . was completed.
A charge registered on 30 Jul 2004 via Charge ID 90158437 with Bank Of Baroda was fully satisfied on 11 Jun 2018. was recorded as a recent event.
A charge with Bank Of Baroda of Rs. 57.00 M registered on 30 Jul 2004 with Charge ID 90158437 was modified on 31 Mar 2008. was recorded as a recent event.
The CIN of Rusi Pharma Pvt Ltd is U24230MH1992PTC069066.
Rusi Pharma Pvt Ltd is headquartered at Anchor Building A,Flat No.4D/104, New Mhada Complex Bhoomi Construction, Malwani Mal, Ad West, Mumbai, Maharashtra, 400096.
Rusi Pharma Pvt Ltd was incorporated on 16 October 1992.
The current directors of Rusi Pharma Pvt Ltd are
The primary industry of Rusi Pharma Pvt Ltd is Manufacturing.
Rusi Pharma Pvt Ltd is unlisted.
The authorized capital of Rusi Pharma Pvt Ltd is ₹5.00 M, and the paid-up capital is ₹5.00 M.
The compliance status of Rusi Pharma Pvt Ltd is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX